Switch to
Predicate | Object |
---|---|
rdf:type | |
lifeskim:mentions | |
pubmed:issue |
1
|
pubmed:dateCreated |
1991-3-7
|
pubmed:abstractText |
Granulocyte colony stimulating factor (G-CSF) can safely stimulate the production of neutrophils in normal and neutropenic patients. Phase II studies have shown potential benefit when G-CSF is given after chemotherapy and bone marrow transplantation and in dose intensification studies. Studies in myelodysplasia, chronic neutropenia and AIDS all show great promise. Phase III studies are now in progress, which will help identify precisely the role of this exciting molecule.
|
pubmed:language |
eng
|
pubmed:journal | |
pubmed:citationSubset |
IM
|
pubmed:chemical | |
pubmed:status |
MEDLINE
|
pubmed:issn |
0261-2429
|
pubmed:author | |
pubmed:issnType |
Print
|
pubmed:volume |
9
|
pubmed:owner |
NLM
|
pubmed:authorsComplete |
Y
|
pubmed:pagination |
115-30
|
pubmed:dateRevised |
2007-11-15
|
pubmed:meshHeading |
pubmed-meshheading:1703454-Acquired Immunodeficiency Syndrome,
pubmed-meshheading:1703454-Bone Marrow Transplantation,
pubmed-meshheading:1703454-Chronic Disease,
pubmed-meshheading:1703454-Clinical Trials as Topic,
pubmed-meshheading:1703454-Granulocyte Colony-Stimulating Factor,
pubmed-meshheading:1703454-Humans,
pubmed-meshheading:1703454-Neural Tube Defects,
pubmed-meshheading:1703454-Neutropenia
|
pubmed:year |
1990
|
pubmed:articleTitle |
Clinical studies of granulocyte colony stimulating factor (G-CSF).
|
pubmed:affiliation |
Cancer Research Campaign Department of Medical Oncology, Christie Hospital, Withington, Manchester.
|
pubmed:publicationType |
Journal Article,
Clinical Trial,
Review
|